#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary hypertension Von Willebrand's disease Optic glioma Glomerulonephritis rapidly progressive Myxofibrosarcoma Oesophageal squamous cell carcinoma stage III Eosinophilic oesophagitis Congenital hypotransferrinaemia ROHHAD syndrome Deafness Postprandial hypoglycaemia Non-small cell lung cancer metastatic Bladder cancer Mantle cell lymphoma stage IV Hereditary haemorrhagic telangiectasia More trials…

    Learn about Rare Diseases

    Alagille syndrome – Diagnostics Marginal zone lymphoma refractory – Basic Information Activated PI3 kinase delta syndrome – Diagnostics Mantle cell lymphoma stage III – Trials in Disease Mitochondrial myopathy – Diagnostics Turner’s syndrome – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Ocular melanoma – Basic Information Encephalitis autoimmune – Basic Information Gaucher’s disease type I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd2693 Sodium 1,3-BUTYLENE GLYCOL Alizapride Inaxaplin Lysine Hydrochloride GVV858 JNJ-75276617 Perflubutane CHLOROQUINE PHOSPHATE AMLENETUG Brinzolamide Guanfacine Meropenem Anhydrous Edoxaban Remimazolam Elexacaftor The-630 Alteplase Gemlapodect Tiotropium Bromide Monohydrate More therapies…

    Learn about Your Condition

    Small cell carcinoma Ataxia telangiectasia Mechanical ventilation Urticaria chronic Ependymoma malignant Angiosarcoma recurrent Glioblastoma multiforme Infertility male Impaired gastric emptying Inguinal hernia Arterial stiffness Testicular germ cell tumour Hypersomnia Rheumatic disorder Haemodynamic instability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Elritercept
    Czechia France Germany Spain

  • Study on Long-Term Safety and Pregnancy Outcomes of Pariglasgene Brecaparvovec in Patients with Glycogen Storage Disease Type Ia (GSDIa)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pariglasgene Brecaparvovec
    Denmark Germany Italy The Netherlands Spain

  • Study of sodium zirconium cyclosilicate compared to standard care for managing high blood potassium levels in patients with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperkalaemia
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain

  • Study on Milrinone for Preventing Delayed Brain Ischemia in Patients with Severe Subarachnoid Hemorrhage

    Recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Milrinone
    • Glucose Monohydrate
    France

  • Study of Enoxaparin Treatment in Pregnant Women with Early Fetal Growth Restriction

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Foetal growth restriction
    Investigated Drugs:
    • Enoxaparin Sodium
    Portugal

  • Study on the Effects of AS01B, Ipilimumab, and Nivolumab in Patients with Advanced Melanoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Belgium
Previous Page
1 … 369 370 371 372 373 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!